| Title: | Variants in ALDH1A2 reveal an anti-inflammatory role for retinoic acid and a new class of disease-modifying drugs in osteoarthritis |
| Journal: | Science Translational Medicine |
| Published: | 21 Dec 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/36542696/ |
| DOI: | https://doi.org/10.1126/scitranslmed.abm4054 |
| URL: | http://hdl.handle.net/10044/1/101589 |
Publication 10840
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
More than 40% of individuals will develop osteoarthritis (OA) during their lifetime, yet there are currently no licensed disease-modifying treatments for this disabling condition. Common polymorphic variants in ALDH1A2, which encodes the key enzyme for synthesis of all-trans retinoic acid (atRA), are associated with severe hand OA. Here, we sought to elucidate the biological significance of this association. We first confirmed that ALDH1A2 risk variants were associated with hand OA in the U.K. Biobank. Articular cartilage was acquired from 33 individuals with hand OA at the time of routine hand OA surgery. After stratification by genotype, RNA sequencing was performed. A reciprocal relationship between ALDH1A2 mRNA and inflammatory genes was observed. Articular cartilage injury up-regulated similar inflammatory genes by a process that we have previously termed mechanoflammation, which we believe is a primary driver of OA. Cartilage injury was also associated with a concomitant drop in atRA-inducible genes, which were used as a surrogate measure of cellular atRA concentration. Both responses to injury were reversed using talarozole, a retinoic acid metabolism blocking agent (RAMBA). Suppression of mechanoflammation by talarozole was mediated by a peroxisome proliferator-activated receptor gamma (PPARγ)-dependent mechanism. Talarozole was able to suppress mechano-inflammatory genes in articular cartilage in vivo 6 hours after mouse knee joint destabilization and reduced cartilage degradation and osteophyte formation after 26 days. These data show that boosting atRA suppresses mechanoflammation in the articular cartilage in vitro and in vivo and identifies RAMBAs as potential disease-modifying drugs for OA.</p>
25 Authors
- Linyi Zhu
- Pragash Kamalathevan
- Lada A. Koneva
- Jadwiga Miotla Zarebska
- Anastasios Chanalaris
- Heba Ismail
- Akira Wiberg
- Michael Ng
- Hayat Muhammad
- John Walsby-Tickle
- James S.O. McCullagh
- Fiona E. Watt
- The Oxford Hand Surgical Team
- Stephen N. Sansom
- Dominic Furniss
- Matthew D. Gardiner
- Tonia L. Vincent
- Nick Riley
- Michelle Spiteri
- Ian McNab
- Christopher Little
- Lucy Cogswell
- Paul Critchley
- Henk Giele
- Rebecca Shirley
Enabling scientific discoveries that improve human health